Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PLNP | ISIN: US00973Y1082 | Ticker-Symbol: 0K4
Frankfurt
24.04.25
08:02 Uhr
34,690 Euro
+0,070
+0,20 %
1-Jahres-Chart
AKERO THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
AKERO THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
36,02036,23018:44
36,01036,22018:45

Aktuelle News zur AKERO THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.03.Hedge Fund and Insider Trading News: Warren Buffett, Bill Ackman, Elliott Investment Management, Davidson Kempner, Magnetar Capital, Akero Therapeutics Inc (AKRO), Snowflake Inc (SNOW), and More22
03.03.Akero Therapeutics stock target raised to $75 by H.C. Wainwright2
AKERO THERAPEUTICS Aktie jetzt für 0€ handeln
02.03.Why Akero Therapeutics, Inc. (AKRO) is Skyrocketing So Far in 20257
28.02.Akero Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
28.02.Akero Therapeutics Inc. Q4 Loss Beats Estimates7
28.02.Akero Therapeutics, Inc. - 8-K, Current Report-
28.02.Akero Therapeutics GAAP EPS of -$0.99 beats by $0.172
28.02.Akero Therapeutics Inc.: Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update161-- Reported unprecedented, statistically significant reversal of compensated cirrhosis (F4) due to MASH after 96 weeks of treatment with efruxifermin (EFX) in Phase 2b SYMMETRY study -- -- Completed...
► Artikel lesen
28.02.Akero Therapeutics, Inc. - 10-K, Annual Report-
23.02.Akero Therapeutics, Inc. (AKRO): the Best Performing Pharma Stock So Far in 20259
04.02.Why Akero Therapeutics Inc (AKRO) Is Skyrocketing So Far In 202514
02.02.Why Akero Therapeutics (AKRO) Is Among the Best Booming Stocks to Invest in Now?4
02.02.Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?1
30.01.Akero Therapeutics Inc.: Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares7
30.01.Akero raised to Buy at Bank of America after liver drug data14
29.01.BioAge drops obesity drug; Akero, 89bio cash in on MASH data4
29.01.Akero Therapeutic prices upsized stock offering of $350M3
29.01.Akero Therapeutics Inc.: Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants4
28.01.Why Akero Therapeutics Inc. (AKRO) Surged on Monday3
27.01.Akero Therapeutics announces proposed public offering of common stock2
Seite:  Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1